Corporate News Acadia Pharma GAAP EPS of $0.20 beats by $0.06, revenue of $250.4M beats by $1.56M by Contributor since / Followers 2 weeks ago Acadia Pharma press release (NASDAQ:ACAD): Q3 GAAP EPS of $0.20 beats by $0.06. Revenue of $250.4M (+18.3% Y/Y) beats by $1.56M. Tags: ACAD Continue Reading Previous Qualcomm just reported Q4 results. Here’s why the stock is soaring.Next Virgin Galactic GAAP EPS of -$2.66 beats by $1.10, revenue of $0.4M beats by $0.13M Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. Δ